Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23635728 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)
Condition: Uterine Hemorrhage
Interventions: Drug: Tranexamic acid;   Drug: Mefenamic acid;   Drug: Placebo;   Drug: Mirena (Levonorgestrel IUS, BAY86-5028)

Study has passed its completion date and status has not been verified in more than two years.